NanoViricides Inc. (NNVC)

[JG36]

You make it sound like "buying innovation" is a bad thing. For many small drug development companies having their innovation bought out is a desirable outcome. They don't have the cash to do phase 3 trials, they don't have a distribution system, they don't want to be in the pill manufacturing business. If there was no possibility of getting funding from big pharma in the latter stages of testing NNVC stock would be even lower right now, because investors would know that another big stock distribution would be required to fund it. Take away the option of selling the results to big pharma and you have taken away one more possible way for this investment to have a positive outcome.